Li-Rong Liang
Overview
Explore the profile of Li-Rong Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Qi R, Zhao L, Liang L, Song J, Zhou X, et al.
Int Immunopharmacol
. 2025 Feb;
148:114141.
PMID: 39930646
Doxorubicin (DOX) is a widely used chemotherapy drug for cancer while leads to several cardiac disorders including cardiomyopathy and heart failure. Aprocitentan is a novel dual endothelin-1 receptor antagonist and...
2.
Lu C, Li J, Wang Q, Wang R, Pan X, Chen X, et al.
Tob Induc Dis
. 2024 Nov;
22.
PMID: 39610647
Introduction: Evidence of different smoking cessation interventions varies and has been assessed in many Cochrane reviews. We conducted an overview of these Cochrane reviews to summarize the effects of current...
3.
Jing C, Zhang L, Feng L, Li J, Liang L, Hu J, et al.
Front Cardiovasc Med
. 2024 Nov;
11:1449058.
PMID: 39484015
Background: This study aimed to synthesize the recommendations for prediction models in cardiovascular clinical practice guidelines (CPGs) and assess the methodological quality of the relevant primary modeling studies. Methods: We...
4.
Liang L, Liu B, Cao S, Zhao Y, Zeng T, Zhai M, et al.
Zool Res
. 2024 May;
45(3):663-678.
PMID: 38766748
A growing number of studies have demonstrated that repeated exposure to sevoflurane during development results in persistent social abnormalities and cognitive impairment. Davunetide, an active fragment of the activity-dependent neuroprotective...
5.
Kang H, Cao S, Shao S, Liang L, Tong Z
Front Med (Lausanne)
. 2024 Feb;
11:1351589.
PMID: 38384409
Background: Silicosis shows an increasing trend with the development of new industries. However, the potential biomarkers for predicting the disease severity are lacking. A novel inflammatory marker, the systemic immune-inflammation...
6.
Lu C, Jin X, Wang Q, Chen X, Zheng R, Wang C, et al.
Tob Induc Dis
. 2023 Nov;
21:150.
PMID: 38026501
Introduction: Traditional Chinese medicine (TCM) may have special advantages in facilitating smoking cessation, but consensus on effectiveness is lacking. We aim to comprehensively review, update, and refine current evidence on...
7.
Zhang M, Li X, Zhang Z, Liu Y, Song J, Liu X, et al.
Cell Stress Chaperones
. 2022 Dec;
28(1):91-103.
PMID: 36510036
Doxorubicin (DOX) is a chemotherapeutic drug for a variety of malignancies, while its application is restricted by the cardiovascular toxic effects characterized by oxidative stress. Ferroptosis is a novel iron-dependent...
8.
Li X, Song J, Zhang Z, Zhang M, Liang L, Miao R, et al.
Free Radic Biol Med
. 2022 Nov;
193(Pt 1):459-473.
PMID: 36334846
Hypertension is one of the leading causes of chronic kidney disease characterized with renal fibrosis. This study aimed to investigate roles and mechanisms of sirtuin 7 (SIRT7) in hypertensive renal...
9.
Hua C, Liu X, Liang L, Wang L, Zhong J
Front Cardiovasc Med
. 2022 Feb;
8:784044.
PMID: 35155600
Cardiovascular diseases (CVDs) are still the main cause of morbidity and mortality worldwide and include a group of disorders varying from vasculature, myocardium, arrhythmias and cardiac development. MicroRNAs (miRs) are...
10.
Liu Y, Dong Z, Song J, Liang L, Sun L, Liu X, et al.
Exp Cell Res
. 2022 Jan;
411(2):113017.
PMID: 34998813
Hypertensive renal injury is accompanied by tubular interstitial fibrosis leading to increased risk for renal failure. This study aimed to explore the influences of miR-122-5p in hypertension-mediated renal fibrosis and...